OAC
ASMB icon

OMERS Administration Corp’s Assembly Biosciences ASMB Stock Holding History

OMERS Administration Corp’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$225K Sell
8,100
-7,498
-48% -$214K ﹤0.01% 892
2025
Q4 		$530K Buy
+15,598
New +$502K ﹤0.01% 650

Other funds holding ASMB

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

OMERS Administration Corp's ASMB Position: Q1 2026 in Review

OMERS Administration Corp reduced its Assembly Biosciences (ASMB) stake by 48% in Q1 2026, selling an estimated $214K and leaving 8,100 shares worth $225K. The position accounts for ﹤0.01% of the portfolio, ranked #892.

OMERS Administration Corp first reported a position in ASMB in Q4 2025 and has held it in 2 quarters since. The position peaked at $530K in Q4 2025. 75 funds tracked by Wall St. Rank hold ASMB as of Q1 2026.

  • OMERS Administration Corp held 8,100 shares of Assembly Biosciences worth $225K as of Q1 2026.
  • OMERS Administration Corp sold 7,498 Assembly Biosciences shares in Q1 2026, an estimated $214K.
  • Assembly Biosciences made up ﹤0.01% of OMERS Administration Corp's portfolio in Q1 2026, its #892 holding.
  • OMERS Administration Corp first reported a position in Assembly Biosciences in Q4 2025 and has held it in 2 quarters since.
  • OMERS Administration Corp's Assembly Biosciences position peaked at $530K in Q4 2025.
  • 75 funds tracked by Wall St. Rank held Assembly Biosciences as of Q1 2026.

Based on OMERS Administration Corp's 13F filing for Q1 2026, filed 15 May 2026.